Inscription à l’infolettre

Publications

Publications récentes

  • 12 décembre 2025

    CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling.

    Minati R, Cahuzac M, Perrault J, Lullier V, Apavaloaei A, Bonneil E, Courcelles M, Lanoix J, Kina E, Perreault C, Thibault P
    Cell Rep 2025-12-12 ;44( 12 ):116676

  • 1er décembre 2025

    Extracellular Vesicles Define Discrete Nano-Based Niches Within the Human Haematopoietic System.

    Grenier-Pleau IJ, Wells CJ, Holmes SM, Hall C, Vermeulen M, de Villiers CA, Penders J, Pedersen SV, Dick SA, Bonneil E, Slobodyanyuk M, Nagree MS, Kaur J, McNaughton AJM, Beaulieu J, Stevens MM, Xie SZ, Rauh MJ, Postovit LM, Knapp D, Reimand J, Tyryshkin K, Thibault P, Craig AW, Rudan JF, Mann S, Chan EYW, Abraham SA
    J Extracell Vesicles 2025-12-01 ;14( 12 ):e70181

  • 18 novembre 2025

    Development of a Genetically Encoded and Potent PDE6D Inhibitor.

    Gómez-Mulas A, Schaffner-Reckinger E, Peeters H, Chippalkatti R, Dautbasic A, Smith M, Ismail S, Abankwa DK
    Chembiochem 2025-11-18 ;e202500739

  • 11 novembre 2025

    Ubiquitination of MHC class II molecules regulates B-cell development and response to antigens in mice.

    Raymond M, Balthazard R, Zahn A, Silva-Barrios S, Hammami A, Majdoubi A, Lee JS, Connolly A, Sabourin A, Galbas T, Moulefera MA, Ogura H, Ishido S, Balood M, Talbot S, Gagnon E, Di Noia JM, Stäger S, Thibodeau J
    J Immunol 2025-11-11 ;

  • 10 novembre 2025

    CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.

    Lehnertz B, Langouët M, Corneau S, MacRae T, Joe M, Schmidt EN, Spinella JF, Mayotte N, Moore S, Tellechea MF, Boivin I, Papineau L, Rojas-Sutterlin S, Tual M, Cortes CJ, Chagraoui J, Tomellini E, Desse V, Gagnon E, Macauley MS, Sauvageau G
    Mol Ther 2025-11-10 ;

  • 1er novembre 2025

    CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability.

    Boucher J, Houles T, Berliocchi E, Lavoie G, MacLeod G, Saba-El-Leil MK, Angers S, Meloche S, Roux PP
    Cell Rep 2025-11-01 ;44( 11 ):116495

  • 27 octobre 2025

    Moesin controls cell-cell fusion and osteoclast function.

    Dufrançais O, Plozza M, Juzans M, Métais A, Monard SC, Bordignon PJ, Verdys P, Sanchez T, Bergert M, Halper J, Panebianco CJ, Mascarau R, Gence R, Arnaud G, Ben Neji M, Maridonneau-Parini I, Le Cabec V, Boerckel JD, Pavlos NJ, Diz-Muñoz A, Lagarrigue F, Blin-Wakkach C, Carréno S, Poincloux R, Burkhardt JK, Raynaud-Messina B, Vérollet C
    J Cell Biol 2025-10-27 ;224( 11 ):

  • 23 octobre 2025

    High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.

    Richard-Carpentier G, Béliveau F, Lacoste S, Khakipoor B, Lisi V, Vladovsky M, Marquis M, Spinella JF, Gendron P, Lemieux S, Lavallée VP, Sauvageau G, Hébert J
    Biomark Res 2025-10-23 ;13( 1 ):133

Voir plus de publications